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ABSTRACT 
Physical therapists are seeing more and more elderly individuals with 
acute, chronic, or multiple disease conditions. Many of these conditions are 
treated with medications. It is common for the geriatric patient to be taking 
multiple medications. Polypharmacy is a relevant concern for physical therapists 
as adverse effects are often revealed in the musculoskeletal and central nervous 
systems. These manifestations can cause adverse effects in evaluation, 
treatment, and outcomes. 
The pu~pose of this study is to discuss the common non-prescription and 
prescription medications consumed by the elderly, describe the biologic and 
physiologic changes that occur with age and how these changes alter 
medication effects, and to discuss the physical therapist's role in treating 
geriatric individuals who take multiple medications. The procedure will be a 
literature review. 
The study will lead to increased awareness and knowledge of 
pharmacology in physical therapy. The information will lead to more effective 
treatment and education for the patient and family. 
viii 
CHAPTER I 
INTRODUCTION 
The life span of individuals today is increased by prevention measures, 
early recognition of disease, and improved medical technology. With these 
advances prolonging the life span, society will be noticing more and more people 
over the age of 65. The growing elderly population is producing more people 
with chronic and acute disease conditions, as well as multiple conditions. These 
conditions can be treated or monitored with medications.1 These medications 
are purchased and consumed regularly by the geriatric population.2 
It has been found that '1he elderly are the primary drug users, taking at 
least fifty percent of the total drugs consumed.,,3(P174) It has also been estimated 
that between 87% and 92% of prescription and non-prescription medications are 
used in a multiple fashion (taking more than one at a time). 
Prevention, diagnosis, or therapy is the rationale behind the prescribing of 
medications to the population in general, including the geriatric population. 
Polypharmacy (consuming multiple medications daily) places an individual at 
risk for adverse drug reactions. Adverse drug reaction is defined by the World 
Health Organization as "any response to a drug which is noxious, unintended, 
and which occurs at doses used in people for prophylaxis, diagnosis, or 
1 
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therapy.,,4(p449) The prevalence of adverse drug reactions increases after the age 
of 60 years and especially for those who take five or more medications daily.5 
"Adverse drug reactions increase the morbidity, mortality, and cost of care in 
elderly individuals.,,4(p449) 
Adverse drug reactions resulting from polypharmacy are relevant to 
physical therapy because their effects are often on the musculoskeletal system 
and central nervous system. Musculoskeletal concerns related to polypharmacy 
include fractures, ligament damage, and contusions. These are often a direct 
result of falls that occur due to multiple medication use. Central nervous system 
effects often include involuntary movements, dizziness, vertigo, and ataxia. For 
example, an individual may fall due to adverse effects of their medication. This 
fall could result in a hip fracture for which the individual would receive physical 
therapy. The person may show some signs of dizziness during therapy which 
could be directly related to the medications that he or she takes. It is the 
responsibility of the physical therapist to treat the fracture and search for the 
underlying problem which may be the individual's medication use. It is likely that 
the effects of medication can make physical therapy challenging if signs and 
symptoms of multiple medication use show up in other systems of the body. 
Physical therapists should be familiar with the types of medications, 
possible adverse reactions, and the treatment of complications that may arise as 
a result of polypharmacy. This paper will discuss the common non-prescription 
and prescription medications consumed by the elderly, describe biologic and 
3 
physiologic changes of the body with age, and discuss the physical therapist's 
role in treating geriatric individuals who take multiple medications. 
CHAPTER II 
PHARMACOLOGIC AGENTS 
The geriatric population consumes a variety of non-prescription and 
prescription drugs to help manage cardiovascular disease, genitourinary 
problems, musculoskeletal problems, respiratory disease, and central nervous 
system disturbances. The non-prescription and prescription drugs can be 
classified by subcategories. Each category will be discussed relative to 
purpose, considerations for use, and adverse reactions.3,4 
Non-Prescription Drugs 
The first major category of medications used by the elderly are non-
prescription (over-the-counter) drugs. This major category can be broken down 
into four smaller categories: vitamins, analgesics, laxatives, and antacids. 
Vitamins are the first group of non-prescription drugs to be discussed. 
Their purpose for use in the elderly is to correct deficiency states due to genetic 
factors, insufficient dietary intake, or malabsorption.6 They are also used to 
prevent anemia. The major precaution for the elderly patient is toxicity due to 
taking vitamins that are not needed or which exceed the recommended daily 
dosage. Another precaution with prolonged or inappropriate use is reduced 
renal function.6 
4 
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The second group of over-the-counter medications used widely by the 
elderly are analgesics. Non-prescription analgesics are referred to as mild 
analgesics. Strong analgesics require a physician's prescription and will be 
discussed later. 
The purpose of the mild analgesic is to provide pain relief. Aspirin and 
acetaminophen (Tylenol) fall into the mild category. Aspirin is best for pain relief 
and it also relieves inflammation for conditions such as arthritis. Acetaminophen 
eliminates fever and pain, but it has very little anti-inflammatory action. When 
the geriatric patient uses these medications, it is important to pay attention to 
dosage as adverse reactions are dose related and include heartburn, 
gastrointestinal bleeding, nausea and vomiting, cramps, constipation, tinnitus, 
deafness, headache, and dizziness.6 Examples of mild analgesics are listed in 
Table 1. 
Many elderly individuals buy laxatives over-the-counter. Laxatives aid in 
keeping bowel movements regular. Although there are many types of laxatives 
available today, the focus will be on these four: osmotically-active agents (milk 
of magnesia, Epsom salt, and Fleet's enema), mucosal irritants (caster oil and 
Dulcolax), a lubricant (mineral oil), and bulk increasing agents (bran, Metamucil, 
and Fibercon).6 The osmotically-active agents work by retaining water in the 
intestines. If an elderly individual has renal dysfunction, he or she would want to 
avoid this type of laxative. Caster oil and Dulcolax work by "irritating" the 
intestine and forcing substances to move through it. This group tends to have 
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Table 1.-Mild Analgesics6 
• Tylenol 
• Aspirin 
• Zactane 
• Darvon 
• Fiorinal 
• Percodan 
• Zactirin 
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an "excessive effect" so the elderly person would not want to take this right 
before bed. Mineral oil slows down water reabsorption in the intestine. The 
body may have difficulty absorbing fat soluble vitamins with excessive use of this 
product. An elderly individual who increases the amount of bran in his or her 
diet may also receive laxative effects, but he or she should drink adequate fluids 
to prevent obstructions in the bowel.s Examples of laxatives are listed in Table 
2. 
The final group of non-prescription drugs commonly used by the geriatric 
population is antacids. Antacids "neutralize or remove acid from the gastric 
contents and decrease peptic activity."S(P1042) The antacids carry a warning 
related to their sodium content. The sodium precaution should especially be 
noted by individuals diagnosed with hypertension, heart disease, renal failure, or 
cirrhosis of the liver, as increased sodium intake can cause complications of 
their existing condition.s Adverse reactions include hypertension, edema, 
constipation, toxicity, and in rare cases, neurological, neuromuscular, and/or 
cardiovascular impairment.s Examples of antacids are listed in Table 3. 
Prescription Drugs 
The second major category of drugs purchased and consumed by the 
elderly is prescription drugs. This major category can also be divided into 
smaller groups which are strong analgesics, antihypertensive agents, anti-
arrhythmic drugs, anti-atherosclerosis medications, and drugs to treat central 
8 
Table 2.-Laxatives6 
• Epson Salt 
• Milk of Magnesia 
• Fleet's Enema 
• Glycerin Suppositories 
• Ducolax 
• Caster Oil 
• Phenolax 
• Metamucil 
• Surfak 
9 
Table 3.-Antacids6 
• Amphojel 
• Riopan 
• Aludrox 
• Camalox 
• Creamalin 
• Oi-Gel 
• Maalox 
• Mylanta 
• WinGel 
10 
nervous system disorders.6 Each category will be discussed relative to 
purpose, considerations for use, and adverse reactions. 
The purpose of strong analgesics is to aid in the elimination of pain. 
Examples of strong analgesics are morphine and Demerol.6 This group is most 
often used for moderate to severe pain or when the source of pain cannot be 
identified or controlled in a timely manner. Strong analgesics produce adverse 
effects more frequently than mild analgesics.6 Dependence and tolerance may 
become issues for the individual.6 Dependence occasionally occurs when the 
individual uses the medication for a chronic condition over a period of many 
years. With extended use, tolerance increases and it may be necessary to 
increase the dosage to receive the therapeutic effect intended. Adverse 
reactions to strong analgesics include nausea and vomiting, respiratory 
depression, constipation, orthostatic hypotension, and sedation. Examples of 
strong analgesics are listed in Table 4. 
Three main types of antihypertensive agents are prescribed to the elderly 
patient with high blood pressure. These include diuretics, vasodilators, and Beta 
blockers.6 The purpose of antihypertensive medications is to decrease the 
individual's cardiovascular risk status by decreasing the workload of the 
myocardium. Diuretics increase the amount of urine the person secretes and 
are generally the first prescribed to combat the problem of high blood pressure.6 
Vasodilators dilate the blood vessels, thus blood flows through the vessels more 
smoothly and effectively. Vasodilators often need to be taken in multiple doses 
11 
Table 4.-Strong Analgesics6 
• Nisentil 
• Leritine 
• Dilaudid 
• Demerol 
• Dolophine 
• Leveprome 
• Pantopon 
12 
daily and this factor makes them quite costly. The price can make it difficult for 
some elderly individuals to continue purchasing their medication. The third type 
of antihypertensive drug is the Beta blockers. These drugs "block inhibiting 
stimuli from the nervous system,,,6(P372) meaning they allow the blood vessels to 
remain dilated which promotes blood flow. Beta blockers are also expensive 
drugs to purchase, so the price could again be a concern or disadvantage. 
Adverse reactions for all antihypertensive drugs are as follows: tachycardia, 
palpitations, increased cardiac work, flushing of the skin, headaches, 
cardiovascular collapse (which consists of bradycardia, hypotension, and heart 
block), and gastrointestinal and central nervous system disturbances.6 
Examples of antihypertensive agents are listed in Table 5. 
Elderly individuals with an irregular heartbeat are often prescribed 
medications classified as anti-arrhythmics. Their purpose is to help alleviate the 
arrhythmic conditions of the heart. Medications are most often prescribed for 
tachycardiac conditions, as individuals with bradycardiac conditions usually 
require a pacemaker. Many of the adverse reactions seen with anti-arrhythmics 
are proportional to the dosage taken. Gastrointestinal discomfort may include 
nausea, vomiting, diarrhea, and abdominal pain. Central nervous system 
disturbances include tinnitus, headaches, visual impairment, drowsiness, ataxia, 
dysarthria, and nystagmus.6 Examples of anti-arrhythmic agents are listed in 
Table 6. 
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Table 5.-Antihypertensive Agents6 
• Reserpine 
• Raudixin 
• Rauwiloid 
• Harmonyl 
• Moderil 
• Aldomet 
• Catapres 
• Ismelin 
• Minipress 
• Lopressor 
14 
Table 6.-Anti-arrhythmic Agents6 
• Quinaglute 
• Cardioquin 
• Quinidex 
• Pronestyl 
• Dilantin Sodium 
• Inderal 
• Norpace 
• Bretylol 
15 
Medications to prevent atherosclerosis are commonly prescribed in the 
geriatric population. The purpose of atherosclerosis medication is to prevent 
hardening of the arterial wall. Adverse reactions to be aware of include 
constipation, nausea, diarrhea, and flushing of the skin.6 Examples of anti-
atherosclerosis agents are listed in Table 7. 
The final category to be discussed is the medications used to treat 
disorders of the central nervous system. It is not uncommon for the geriatric 
population to suffer from insomnia and/or depression. Insomnia is treated with 
hypnotic agents such as barbiturates.6 Barbiturates tend to be misused 
frequently and can produce psychological dependence in elderly individuals.6 
Adverse reactions for the barbiturates include excessive drowsiness, decreased 
reaction time, decreased coordination, decreased motor function, vertigo, and 
ataxia. 
Loss of a spouse or friends, failing health conditions, feelings of 
uselessness, and a change in living environment can contribute to depression in 
the geriatric population. For these reasons, antidepressant medications are 
commonly prescribed. Tricyclics, Monamine Oxidase Inhibitors (MAO 
Inhibitors), and Lithium are three commonly prescribed antidepressant drugs. 
Tricyclics are quite effective, but have a lag time of three to five days before any 
result or improved condition is seen.6 Adverse reactions associated with 
tricyclics are dry mouth, blurred vision, constipation, tachycardia, drowsiness, 
and agitation.6 MAO Inhibitors tend to react with certain types of food, which can 
16 
Table 7.-Anti-atherosclerosis Agents6 
• Questran 
• Colestid 
• Cytellin 
• Lorelco 
• Norlutate 
• Anavar 
17 
result in adverse reactions such as hypertensive crisis and, more severely, 
death. Another possible adverse reaction to MAO Inhibitors is postural 
hypotension. Lithium is the third most common drug given to treat depression. 
Adverse reactions to be aware of regarding Lithium include tremors, anorexia, 
nausea, increased thirst, decreased concentration, and decreased thyroid 
function. 6 Examples of antidepressant agents are listed in Table 8. 
In this section, two major categories of drugs (non-prescription and 
prescription) have been discussed. The medications were discussed relative to 
their purpose, considerations for use, and possible adverse reactions. The next 
chapter will focus on the biologic and physiologic changes in the geriatric 
population. It will be the purpose of the following chapter to determine why 
adverse reactions occur as a result of polypharmacy in the aging individual. 
18 
Table 8.-Antidepressants6 
• Elavil 
• Vivactil 
• Amitriptyline 
• Tofranil 
• Norpramin 
• Sinequan 
• Marplan 
• Nardil 
• Eskalith 
CHAPTER III 
BIOLOGIC AND PHYSIOLOGIC CHANGES OF AGING 
The age of an individual is a major variable in determining the possibility 
of an adverse drug reaction? Adverse drug reactions are most likely to occur at 
both ends of the age spectrum, infant and elderly? When prescribing 
medications, physicians often fail to give enough consideration to the differing 
needs of young adults, adults, and the elderly? 
With increasing age, individuals are found to be more susceptible to the 
age-related changes that affect drug deposition and response. The biologic and 
physiologic changes that occur in the aging individual are extremely significant 
when determining why adverse reactions occur.8 Five areas that are affected by 
increasing age are absorption, distribution, metabolism, excretion, and tissue 
sensitivity. Each area has specific changes that occur, but it is the combined 
changes in all areas that affect the aging individual and his or her medication 
use. 
The absorption process of medications is affected by increasing age, 
however, not to the same degree as other body processes.8 In the elderly, the 
absorption rate of drugs into the circulatory system is slowed, which hinders the 
therapeutic effects of the drug.8 Age-related changes that affect absorption and 
19 
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lead to adverse drug reactions are decreased absorptive surface area of cells 
and tissues, decreased splanchnic blood flow, increased gastric pH, altered 
gastrointestinal motility, and unusual eating habits.7,s 
Changes in distribution processes occur as one ages.s Changes in body 
composition and a decrease in protein are two factors to be discussed. Age-
related changes in body composition include decreased lean body mass and 
total body water, and increased total body fat. 7,S The composition changes affect 
the amount of area into which the drug is released and result in an increased 
drug concentration in the body leading to adverse reactions.s Secondly, 
distribution can be affected by a decrease in the amount of serum albumin, a 
protein that allows drugs to bind to the correct substances in the body.s This 
means that there are fewer binding sites available for the drug. 
Metabolism is another area that is affected by age. As age increases, 
metabolism slows down and drug metabolizing enzymes are decreased.s If the 
metabolic process is altered, no detoxification can occur. If detoxification does 
not occur, tissues receiving the drug will become over medicated. Over 
medication leads to improper results from the drug and occasionally toxicity.9 
Excretion is the fourth process that is commonly slowed by aging. 
Excretion primarily deals with kidney function. With slowed renal function, 
medications leave the body more slowly and the potential for drug accumulation 
and over medication is increased.s Age-related changes that affect the rate of 
21 
excretion in the elderly are decreased renal blood flow, decreased glomerular 
filtration rate, and decreased tubular secretory function. 7,s 
Tissue sensitivity is the final area to be discussed. The geriatric 
population can have both an increase or decrease in their sensitivity to a drug? 
Hypersensitivity leads to adverse drug reactions because it takes less than the 
normal amount of the drug to get a response. The excess builds up and leads to 
over medication and toxicity. Hyposensitivity can lead to taking excessive 
amounts of the medication to receive the therapeutic benefits. Overdosing on 
the medication leads to adverse drug reactions. The hyper and hyposensitivity 
responses are secondary to altered receptor numbers, altered receptor affinity, 
altered second messenger function, and altered cellular responses.s Figure 1 is 
a representation of changes that occur in the aging body and the relation to drug 
use. 
This chapter has discussed biologic and physiologic changes in the 
elderly individual. The five areas that were covered are the processes of 
absorption, distribution, metabolism, excretion, and tissue sensitivity. The 
following chapter will implicate the physical therapist's role in treating patients 
who consume multiple medications. 
Excretion 
Metabolism 
Liver mass shrinks. 
Hepatic blood flow and 
enzyme activity decline. 
Metabolism drops to 1/2 to 
2/3 the rate of young 
adults. Enzymes lose 
ability to process some 
drugs that reduce irregular 
heart rhythms or breathing 
disorders. 
In kidneys, renal blood flow, 
glomerular filtration rate, renal 
tubular secretion and absorption, 
and number of functional nephrons 
decline. Blood flow and waste 
removal slow. Age-related changes 
lengthen half-life for renally 
excreted drugs. Antidiabetic drugs. 
among others, thus stay in the body 
longer. 
Bladder relies on the neural 
messenger acetylcholine. which 
drugs can reduce. This can cause 
incontinence. 
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Drug-Receptor Interaction 
Brain receptors become 
more sensitive. making 
psychoactive drugs 
very potent 
Circulation 
Vascular nerve controls 
grow less stable. Anti-
hypertensives, for 
example, may overshoot, 
dropping blood pressure 
too low. Digoxin, for 
example, may slow the 
heart beat too much. 
Absorption 
Gastric enzymes and 
gastroacid secretion fall; 
gastric ph rises. Gastric 
emptying rate and 
gastrointestinal motility slow. 
Absorptive capacity of cells 
and active transport 
mechanism decline. 
Distribution 
Lean body mass falls . 
Adipose stores rise. 
Total body water 
declines. raising the 
concentration of water-
soluble drugs, such as 
Digoxin. which can 
cause heart dysfunction. 
Plasma protein tissue 
diminishes. reducing 
sites available for 
protein-bound drugs. 
Figure I. Aging body and drug use. Reprinted from Geriatric Nursing with permission: 
Bezon J. Approaching drug regimens with a therapeutic dose of suspicion. 1991: 12: 180-
182. 
CHAPTER IV 
PHYSICAL THERAPY INTERVENTION 
The goal of rehabilitation is to restore and educate an individual so he or 
she can realize his or her maximum functional ability, positive self-concept, and 
comfortable level of independence.1o Physical therapists see many individuals 
taking multiple medications. The person may be taking medications for the 
same condition for which he or she is receiving physical therapy, or for treatment 
of pre-existing conditions which are unrelated to the physical therapy 
diagnosis. 11 Regardless of the intent, polypharmacy can cause adverse 
reactions that prevent individuals from reaching their highest level of functional 
ability.12 It is therefore important for the physical therapist to realize how 
medications can impact the physical therapy treatment sessions. 
This chapter will discuss the side effects of polypharmacy that are of 
major concern to physical therapists. It will also evaluate how certain treatment 
regimes can alter the intended response of medication. Finally, it will discuss 
the role of the physical therapist as an educator and effective communicator. 
Side Effects 
There are six side effects of polypharmacy that are of concern to the 
physical therapist as they negatively impact the physical therapist's and patient's 
23 
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rehabilitation goals.13 The major side effects include postural hypotension, 
weakness and fatigue, depression and confusion, involuntary movements, 
dizziness and vertigo, and urinary incontinence.1o.13 
Postural hypotension is very common in the elderly who take multiple 
medications. Postural hypotension is a decline in blood pressure when the 
person moves from a supine or sitting position to standing.13 This can make 
working on independent transfers more difficult and time consuming for the 
individual. It is the responsibility of the physical therapist to be aware of normal 
blood pressure changes a patient should experience when switching positions. 
Systolic blood pressure should decrease 10 mmHg or less and diastolic blood 
pressure should increase no more than 5 mmHg.13 The physical therapist 
should take the patient's blood pressure in supine, sitting, and standing and 
record the results. Blood pressure changes can be detected from 30 seconds to 
2 minutes after a postural change.13 Medications responsible for causing 
postural hypotension are listed in Table 9. 
Weakness and fatigue are common general complaints of the geriatric 
population. While these may be caused by physiologic changes and general 
deconditioning, drug use plays a part as wel1. 13 Individuals with acute or chronic 
illnesses may be consuming medications that make them feel tired all the time. 13 
A patient who is tired all the time will not feel like working up to his or her full 
potential to meet the goals of physical therapy. The patient may lack the energy 
to complete basic functional tasks independently or to safely complete exercise 
25 
Table 9.-Agents Causing Postural Hypotension 13 
• Tricyclic Antidepressants 
• Antipsychotics 
• Antihypertensive Drugs 
• Diuretics 
• Vasodilators 
26 
programs. It is the responsibility of the therapist to acknowledge how easily a 
patient is fatigued and check the chart or ask the patient about medications he 
or she might be taking. Examples of medications that cause weakness and 
fatigue are listed in Table 10. 
The use or withdrawal of medications can produce depression and 
confusion in the elderly patient. 13 The depressed patient may lack motivation 
during treatment sessions or for a successful home exercise program.13 
Confused patients may not understand or be able to follow directions. The 
physical therapist will need to be enthusiastic and encouraging to enhance the 
patient's motivation. Positive feedback is also necessary. Written instruction, 
diagrams, and teaching family members may help the confused patient be 
successful with his or her therapy programs. 
Drug-induced parkinsonism and essential tremors are involuntary 
movements that are of concern to the physical therapist.13 Symptoms produced 
by parkinsonism type movement include postural instability, rigidity, 
bradykinesia, and resting tremors. 13 All these symptoms can create functional 
problems during gait, transfers, and sitting balance leading to difficulty with 
activities of daily living. Essential tremors involve the distal parts of the upper 
extremities and are usually absent at rest. 13 These movements interfere with 
precision tasks involving the upper extremities and many activities of daily living. 
For drug-induced parkinsonism and essential tremors, the therapist will focus on 
movement patterns and functional tasks. Adaptation of activities of daily living 
27 
Table 10.-Agents Causing Fatigue and Weakness13 
• Beta Blockers 
• Diuretics 
• Tricyclic Antidepressants 
28 
may need to be made. The individual may need to be appropriately fitted for a 
walker or other assistive device to make ambulation more functional. Chair and 
bed heights may need to be adjusted to make transfers easier for the individual. 
Assistive devices for reaching objects may simplify daily tasks and help to 
ensure patient safety. 
Dizziness and vertigo are often related to falls. Medications can have a 
direct effect on a person's balance and stability. If decreased balance and 
stability are combined with other conditions, such as decreased peripheral 
neurosensation, altered gait patterns, and orthostatic hypotension, the chance of 
a fall occurring is magnified.14 Hip fractures are a serious complication of falls in 
the elderly. It is estimated that approximately 32,000 elderly individuals receive 
hip fractures secondary to drug-induced falls. 14 Psychologically, the individual 
may experience fear of falling a second time which would place restrictions on 
his or her mobility and lifestyle.13 The individual may feel embarrassed about 
this side effect which could lead to decreased participation in social activities 
and isolation.13 The physical therapist needs to perform a thorough evaluation 
and execute the proper treatment plan. Physical therapy intervention should 
focus on static and dynamic balance activities. These are performed while 
sitting, standing, and with gait activities. It is also important that the physical 
therapist review the patient's medical profile and evaluate medications that are 
contributors to falls. The therapist may need to consult with the pharmacist 
regarding the medications the individual is taking. 14 
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Urinary incontinence is often an embarrassing side effect that produces 
anxiety and distress in the individual.13 Motivation and confidence can become 
diminished during rehabilitation treatments. For example, if the patient is 
concerned about incontinence, it removes his or her focus from physical therapy. 
The person also may worry about how others perceive them. To maximize the 
sessions, the physical therapist should consult with the nursing staff or ask the 
patient to schedule their diuretic use around physical therapy sessions.13 
Treatment Techniques and Drug Interactions 
Physical therapists need to realize that some of their treatment 
techniques can alter drug reactions within the systems of the body.11 
Techniques such as exercise, physical agents, and manual therapy will be 
briefly considered. 
Exercise can increase or decrease the amount of blood that flows to an 
area.11 This increase or decrease can alter the therapeutic effects of the drugs. 
Intensity, duration, and mode need to be considered when prescribing exercise 
for therapeutic benefit.11 Physical agents, such as heat and cold, work by 
changing local blood flow. Heat agents cause vasodilatation which leads to 
increased blood flow and drug delivery. Cold agents cause vasoconstriction, 
decreased blood flow, and restricted drug delivery to an area. 11 Manual 
techniques, such as massage, can increase absorption from injection sites and 
increase blood flow moving the drug to the tissues. 11 Figure 2 is a schematic 
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Figure 2. Schematic representation of the interrelationships 
among specific pharmacokinetic factors. Reprinted from Physical 
Therapy with the permission of the APT A: Ciccone C. Basic 
pharmacokinetics and the potential effect of physical therapy 
interventions on pharmacokinetic variables. 1995;75:343-350. 
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representation of the relationship among drug administration and the body 
processes. 
Education and Communication 
Finally, physical therapists have responsibilities as educators and 
effective communicators. Many elderly patients are unaware of the side effects 
that their medications can produce.1s For that reason, physical therapists must 
be educated about polypharmacy in order to educate patients and their families. 
Professional literature, continuing education courses, and contact with 
pharmacists and physicians will help the physical therapist broaden his or her 
pharmacology knowledge.1s Physical therapists will ensure a good knowledge 
base and make their patients feel confident in their abilities. A sound knowledge 
base will allow the physical therapist to refer the patient to other services if 
necessary, defer treatment to another individual or more appropriate time, and 
correctly progress a patient's treatment program. 
Effective communication skills are important to the physical therapist. 
This includes communication with physicians, pharmacists, and patients and 
their families. Physical therapists often have more frequent interaction with their 
patients than do physicians. For that reason, therapists may receive concerns 
or complaints from patients regarding their medications. Contact and 
communication with the physician allows the physical therapist and physician to 
discuss these concerns. Effectively communicating with pharmacists allows for 
a quick reference check on medications a patient may be taking. The 
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pharmacist serves as a resource for questions regarding medications. 
Explanations of effects and what to monitor will be important to the patient and 
family members.15 Discussions with the patient and family regarding effects and 
reactions of medications allow the therapist to make this information known to 
other members of the health care team. Effective communication improves 
patient care and also establishes credibility with other health care professionals. 
This chapter has focused on the role of the physical therapist in dealing 
with polypharmacy. The side effects of polypharmacy and physical therapy 
treatments have been discussed. The importance of education and effective 
communication roles were also established. 
CHAPTER V 
CONCLUSION 
This study was intended to discuss some common non-prescription and 
prescription medications consumed by the elderly; describe the biologic and 
physiologic changes that occur with age and how the changes alter medication 
effects; discuss the physical therapist's role in patient evaluation, treatment, and 
education; and discuss communication with the patient and the health care team 
in relation to polypharmacy. Pharmacologic information is important to the 
physical therapist because medications can adversely effect the individual and 
the physical therapy evaluation, treatment, and outcomes. This holds especially 
true for the geriatric patient, as they often consume multiple medications daily. 
Physical therapists need a knowledge of common pharmacologic agents 
consumed by the elderly. This then opens a door for questions regarding 
physical therapy education. Is it the responsibility of the academic programs to 
ensure that students get a working knowledge in pharmacology or are continuing 
education and independent research sufficient to provide adequate knowledge? 
The answers to these questions are not easily determined; however, answers 
will impact curriculum revision and continuing education programming. 
Whichever route is taken can only help improve the quality of patient care that 
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an individual will receive. It is our responsibility to be accurate and 
knowledgeable in all areas that concern physical therapy. As discussed in this 
paper, pharmacology does impact the lives of our patients and our profession. 
APPENDIX 
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